Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
LetterLetters to the Editor

V/Q SPECT/CT in the Time of COVID-19: Changing the Order to Improve Safety Without Sacrificing Accuracy

Wolfgang M. Schaefer, D. Knollmann and Philipp T. Meyer
Journal of Nuclear Medicine July 2021, 62 (7) 1022-1024; DOI: https://doi.org/10.2967/jnumed.120.261263
Wolfgang M. Schaefer
*Kliniken Maria Hilf Mönchengladbach, Germany E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wolfgang.schaefer@mariahilf.de
D. Knollmann
*Kliniken Maria Hilf Mönchengladbach, Germany E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wolfgang.schaefer@mariahilf.de
Philipp T. Meyer
*Kliniken Maria Hilf Mönchengladbach, Germany E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wolfgang.schaefer@mariahilf.de
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

TO THE EDITOR: Various nuclear medicine associations and colleagues (1–6) have discussed whether a ventilation examination should be included at all when performing ventilation–perfusion (V/Q) scans for diagnosis of pulmonary embolism during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. This consideration was prompted by the concern that a ventilation scan may be an aerosol-prone maneuver and, thus, carry a potential risk of infecting the personnel. Usually, the V/Q scan procedure starts with a ventilation scan, which is followed by a perfusion scan and is eventually closed with a low-dose CT scan, if available. This sequence is traditionally chosen for a V/Q scan because it is easier to surpass the ventilation activity with the perfusion marker than vice versa. Instead of completely eliminating the ventilation scan, resulting in a reduction in specificity (7) and all its negative consequences—such as bleeding events due to unnecessary anticoagulation—we suggest modification of the workflow during the pandemic such that the scan routinely starts with perfusion SPECT (with a somewhat lower administered activity than usual, associated with an increased acquisition time) and proceeds with low-dose CT, if applicable. Ventilation SPECT (with a somewhat higher administered activity than usual, associated with a decreased acquisition time) would be performed only when there are perfusion deficits that are not sufficiently explained by structural findings on low-dose CT. If the patient is SARS-CoV-2–positive or there are COVID-like findings on low-dose CT, it would remain at the discretion of the physician whether a ventilation scan is performed, under appropriate security measures. By doing so, we can reduce the number of ventilation scans and avoid the aforementioned discussion by various nuclear medicine associations and colleagues (1–6).

Figure 1 shows a representative example of the proposed approach in a recently bedridden 80-y-old woman with dyspnea, thoracic pain, and an increased D-dimer level who was referred from an external hospital to rule out pulmonary embolism. We started by injecting about 45 MBq of 99mTc-macroaggregated albumin and performing perfusion SPECT/CT. Since we found relevant perfusion deficits and unremarkable findings on low-dose CT, we subsequently also performed ventilation SPECT with about 88 MBq of 99mTc-Technegas (Cyclomedica) (net ventilated activity calculated from the projection data). The ventilation and perfusion studies showed mismatched findings typical of pulmonary embolism (Fig. 1A). In combination with the normal results from the low-dose CT examination (Fig. 1B), these finding allowed us to detect pulmonary embolism with the highest degree of certainty, according to Gutte et al. (7).

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

V/Q SPECT/CT scan of 80-y-old woman. (A) Slice-by-slice comparison of ventilation and perfusion SPECT showing mismatched findings in both lungs (arrows). Image noise is higher in perfusion images because of lower administered activity in inverted-workflow protocol. (B) Combining SPECT data with low-dose CT proves pulmonary embolism in absence of structural alterations.

Overall, we believe that the suggested routine reversal of the traditional workflow helps to minimize aerosol-prone and potentially infectious maneuvers without compromising the accuracy of pulmonary embolism diagnostics.

Footnotes

  • Published online May 7, 2021.

  • © 2021 by the Society of Nuclear Medicine and Molecular Imaging.

REFERENCES

  1. 1.↵
    1. Zuckier LS,
    2. Moadel RM,
    3. Haramati LB,
    4. Freeman LM.
    Diagnostic evaluation of pulmonary embolism during the COVID-19 pandemic. J Nucl Med. 2020;61:630–631.
    OpenUrlFREE Full Text
  2. 2.
    COVID-19 and ventilation/perfusion (V/Q) lung studies. J Nucl Med. 2020;61(10):23N–24N.
    OpenUrlFREE Full Text
  3. 3.
    Recommandations pour la réalisation de la scintigraphie pulmonaire dans le contexte d’épidémie due au virus Covid-19. Société Française de Médecine Nucléaire et Imagerie Moléculaire website. https://www.sfmn.org/drive/CNP/CODIV-19/Recommandations_GT-ExplorationsPulmonaires30-03-2020.pdf. Accessed May 13, 2021.
  4. 4.
    1. Buscombe JR,
    2. Notghi A,
    3. Croasdale J,
    4. et al.
    COVID-19: guidance for infection prevention and control in nuclear medicine. Nucl Med Commun. 2020;41:499–504.
    OpenUrl
  5. 5.
    1. Das JP,
    2. Yeh R,
    3. Schöder H.
    Clinical utility of perfusion (Q)-single-photon emission computed tomography (SPECT)/CT for diagnosing pulmonary embolus (PE) in COVID-19 patients with a moderate to high pre-test probability of PE. Eur J Nucl Med Mol Imaging. 2021;48:794–799.
    OpenUrl
  6. 6.↵
    1. Vöö S,
    2. Dizdarevic S.
    Single photon emission computed tomography lung perfusion imaging during the COVID-19 pandemic: does nuclear medicine need to reconsider its guidelines? Nucl Med Commun. 2020;41:991–993.
    OpenUrl
  7. 7.↵
    1. Gutte H,
    2. Mortensen J,
    3. Jensen CV,
    4. et al.
    Detection of pulmonary embolism with combined ventilation-perfusion SPECT and low-dose CT: head-to-head comparison with multidetector CT angiography. J Nucl Med. 2009;50:1987–1992.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 62 (7)
Journal of Nuclear Medicine
Vol. 62, Issue 7
July 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
V/Q SPECT/CT in the Time of COVID-19: Changing the Order to Improve Safety Without Sacrificing Accuracy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
V/Q SPECT/CT in the Time of COVID-19: Changing the Order to Improve Safety Without Sacrificing Accuracy
Wolfgang M. Schaefer, D. Knollmann, Philipp T. Meyer
Journal of Nuclear Medicine Jul 2021, 62 (7) 1022-1024; DOI: 10.2967/jnumed.120.261263

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
V/Q SPECT/CT in the Time of COVID-19: Changing the Order to Improve Safety Without Sacrificing Accuracy
Wolfgang M. Schaefer, D. Knollmann, Philipp T. Meyer
Journal of Nuclear Medicine Jul 2021, 62 (7) 1022-1024; DOI: 10.2967/jnumed.120.261263
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Business Model Beats Science and Logic: Dosimetry and Paucity of Its Use
  • Determining PSMA-617 Mass and Molar Activity in Pluvicto Doses
  • The Value of Functional PET in Quantifying Neurotransmitter Dynamics
Show more Letters to the Editor

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire